Navigation Links
Lilly Announces Continued Commitment to Transparency with Faculty Registry
Date:7/31/2009

INDIANAPOLIS, July 31 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY) launched an online registry detailing recent payments it has made to physicians and other health care professionals - a report known as its "faculty registry." The data are for the first quarter of 2009; Lilly will update the registry quarterly going forward.

Lilly faculty are physicians and other health care professionals contracted to provide specific services on behalf of Lilly and the Lilly alliance partnerships. Faculty appearing in the registry either advised Lilly or conducted medical lectures designed for health care professionals and patient education. The site discloses each professional's name, location, description of the services provided and the compensation paid, among other details.

"This registry is consistent with Lilly's efforts to increase transparency," said Jack Harris, M.D., Lilly's vice president of its U.S. medical division. "We see greater transparency as integral to rebuilding trust in our industry."

Nearly 3,400 physicians and other health care professionals are in the dataset. The average payment per service provided is just over $1,000, with health care professionals conducting six activities on average. The data are available at www.lillyfacultyregistry.com.

"Our contracted faculty are key resources in our efforts to improve individual patient outcomes," Harris said. "They advise us on how to bring the best new cures and treatments to market, and give lectures to their peers on Lilly products and disease-state information to help keep them current on the ever-changing field of medicine. And many of our faculty educate patients, at the request of their treating physician, on how to use the Lilly medicine prescribed to them."

Lilly's faculty registry is part of its commitment to enhancing transparency. In 2004, Lilly became the first company to voluntarily make public its clinical trials and its clinical trials data at www.lillytrials.com. In 2007, Lilly added another first by publicly reporting all of its educational grants and charitable contributions and, each quarter, posting the data online at www.lillygrantoffice.com.

Lilly announced last September it would begin to voluntarily disclose physician payments starting in the second half of 2009. In February 2009, Lilly entered into a Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services and was required to disclose the information.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
2. Lilly Receives Award From National Medical Association
3. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
4. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
5. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
6. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
7. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
8. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
9. Lilly Declares Third-Quarter Dividend
10. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
11. Eli Lilly and Company Announces New Drug Discovery Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
Breaking Medicine Technology: